These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37588679)

  • 1. Are European clinical trial funders policies on clinical trial registration and reporting improving? A cross-sectional study.
    O'Riordan M; Haslberger M; Cruz C; Suljic T; Ringsten M; Bruckner T
    J Clin Transl Sci; 2023; 7(1):e166. PubMed ID: 37588679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoption of World Health Organization Best Practices in Clinical Trial Transparency Among European Medical Research Funder Policies.
    Bruckner T; Rodgers F; Styrmisdóttir L; Keestra S
    JAMA Netw Open; 2022 Aug; 5(8):e2222378. PubMed ID: 35913742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
    Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
    JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK.
    Knowles RL; Ha KP; Mueller J; Rawle F; Parker R
    BMJ Open; 2020 Feb; 10(2):e035283. PubMed ID: 32071191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register.
    Mirjam Keestra S; Rodgers F; Gepp S; Grabitz P; Bruckner T
    Clin Trials; 2022 Apr; 19(2):217-223. PubMed ID: 35168372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top health research funders' guidance on selecting journals for funded research.
    Shamseer L; Cobey KD; Page MJ; Brehaut JC; Grimshaw JM; Straus SE; Stewart LA; Moher D
    F1000Res; 2021; 10():100. PubMed ID: 33953906
    [No Abstract]   [Full Text] [Related]  

  • 9. Adopting recommendations for implementing patient involvement in cancer research: a funder's approach.
    Costa Alencar AB; Selig WKD; Geissler J; Bereczky T; Ubide A; Haerry D; Stephens R; Behan V
    Res Involv Engagem; 2023 Mar; 9(1):6. PubMed ID: 36859346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds.
    Viergever RF; Hendriks TC
    Health Res Policy Syst; 2016 Feb; 14():12. PubMed ID: 26892771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Funders' data-sharing policies in therapeutic research: A survey of commercial and non-commercial funders.
    Gaba JF; Siebert M; Dupuy A; Moher D; Naudet F
    PLoS One; 2020; 15(8):e0237464. PubMed ID: 32817724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
    Miller J; Ross JS; Wilenzick M; Mello MM
    BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional dashboards on clinical trial transparency for University Medical Centers: A case study.
    Franzen DL; Carlisle BG; Salholz-Hillel M; Riedel N; Strech D
    PLoS Med; 2023 Mar; 20(3):e1004175. PubMed ID: 36943836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve the implementation of workplace-based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity.
    Wolfenden L; Goldman S; Stacey FG; Grady A; Kingsland M; Williams CM; Wiggers J; Milat A; Rissel C; Bauman A; Farrell MM; Légaré F; Ben Charif A; Zomahoun HTV; Hodder RK; Jones J; Booth D; Parmenter B; Regan T; Yoong SL
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012439. PubMed ID: 30480770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute.
    Whitlock EP; Selby JV; Dunham KM; Fernandez A; Forsythe LP; Norquist G
    F1000Res; 2019; 8():288. PubMed ID: 31131095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of clinical trials: a review of research funders' guidelines.
    Dwan K; Gamble C; Williamson PR; Altman DG
    Trials; 2008 Nov; 9():66. PubMed ID: 19032743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.